STREAM (Standardised Treatment Regimens of Anti-tuberculosis drugs for Multidrug-Resistant Tuberculosis) Stage 1 demonstrated non-inferior efficacy of a short regimen for rifampicin-resistant TB (RR-TB) compared to a long regimen as recommended by the World Health Organization. This study analyzed factors associated with a definite or probable failure or relapse (FoR) event in participants receiving the short regimen. The factors associated with FoR outcomes identified in this study should be considered when determining the optimal shortened treatment regimen.
Published: August 1, 2022
Sign up to receive our monthly Research Roundup email, which offers a selection of new public health research from major journals.
Recent Abstracts
RESET Alcohol – Public opinion, attitudes and support for government action on alcohol…
RESET Alcohol – Public opinion, attitudes and support for government action on alcohol…
Childhood Lead Exposure Prevention: Assessment of Blood Lead Surveillance Capacity in Colombia
Childhood Lead Exposure Prevention: Inventory of Blood Lead Surveillance Capacity Indonesia
The Perception of Air Quality and Community Resilience Towards Air Pollution Issues in…
Effect of women empowerment on treatment-seeking practice for sexually transmitted infections among women…
Stage at diagnosis and survival among adult patients with cancer in Rwanda: A…
Impact of nutrient warning labels on Colombian consumers’ selection and identification of food…
A Systems Map of the Challenges of Climate Communication
Increased Taxes and Regulation of Indian Cigarillos (Bidi) Industry: Effects on Revenue and…